Literature DB >> 20091324

Metabolic consequences of incorrect insulin administration techniques in aging subjects with diabetes.

Sandro Gentile1, Mariano Agrusta, Giuseppina Guarino, Lucia Carbone, Vincenzo Cavallaro, Iarba Carucci, Felice Strollo.   

Abstract

Only few insulin-treated (IT) people with diabetes mellitus (DM) reach the target due to poor compliance and/or to sedentary lifestyle and/or to inadequate treatment regimen. The latter may be also brought about by often overlooked factors including insulin injection into altered skin areas, often brought about by incorrect habits, namely needle reutilization or poor compliance to the suggestion to continuously rotate skin injection areas. The aim of our study was to evaluate the rate of skin lesions within the sites commonly used for insulin injection in our IT DM patients and to verify whether a short-acting insulin analogue yielded different metabolic effects when injected in altered vs. normal skin areas. One hundred and eighty well-trained IT people with type 1 and type 2 DM (64 ± 15 years of age) consecutively referring to our unit underwent a standard clinical examination involving an accurate skin inspection protocol meant at looking for any alterations eventually affecting all possible injection sites, including bruising, multiple needle pricks and lipodystrophic nodules (LN). They were also tested for HPLC HbA1c determination and asked to fill in a standard questionnaire on injection habits. Furthermore, seven male, T1DM glulisine-glargine basal-bolus-treated patients in this group were randomly injected 10 IU glulisine into either normal skin (NS) or an LN by a nurse before a standard, 405 kcal breakfast, for blood glucose and free insulin determination at 0, 30, 45, 60, 75, 90, 120 and 150 min. More lesions were found in people over sixty (P < 0.01) and in women (P < 0.05). A higher prevalence of HbA1c >7.5% was found in patients with lesions (with an O.R. of 3.74) and further confirmed by data obtained from head-to-head comparison of insulin injection into an LN and NS. In fact, injection into an LN proved to impair and slow down insulin absorption, resulting in a higher absolute value and a larger variability of blood glucose levels than those observed by utilizing NS. This suggests us to pay more attention to all aspects of patient-team relationship to try and obtain good metabolic control in all people with diabetes and even more in the elderly.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20091324     DOI: 10.1007/s00592-009-0172-x

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  11 in total

1.  Model study of the pressure build-up during subcutaneous injection.

Authors:  Maria Thomsen; Anier Hernandez-Garcia; Joachim Mathiesen; Mette Poulsen; Dan N Sørensen; Lise Tarnow; Robert Feidenhans'l
Journal:  PLoS One       Date:  2014-08-14       Impact factor: 3.240

2.  Comment on the New Indian Injection Technique Recommendations: Critical Appraisal of the Real-World Implementation of the Current Guidelines.

Authors:  Felice Strollo; Sandro Gentile
Journal:  Diabetes Ther       Date:  2017-04-26       Impact factor: 2.945

3.  Insulin-Related Lipohypertrophy: Lipogenic Action or Tissue Trauma?

Authors:  Anjana Barola; Pramil Tiwari; Anil Bhansali; Sandeep Grover; Devi Dayal
Journal:  Front Endocrinol (Lausanne)       Date:  2018-10-30       Impact factor: 5.555

4.  Prevalence, Risk Factors, and Clinical Characteristics of Lipodystrophy in Insulin-Treated Patients with Diabetes: An Old Problem in a New Era of Modern Insulin.

Authors:  Yotsapon Thewjitcharoen; Hussamon Prasartkaew; Phatharaporn Tongsumrit; Saruda Wongjom; Chatnapa Boonchoo; Siriwan Butadej; Soontaree Nakasatien; Krittadhee Karndumri; Veekij Veerasomboonsin; Sirinate Krittiyawong; Thep Himathongkam
Journal:  Diabetes Metab Syndr Obes       Date:  2020-11-26       Impact factor: 3.168

5.  Role of Structured Education in Reducing Lypodistrophy and its Metabolic Complications in Insulin-Treated People with Type 2 Diabetes: A Randomized Multicenter Case-Control Study.

Authors:  Sandro Gentile; Giuseppina Guarino; Teresa Della Corte; Giampiero Marino; Ersilia Satta; Maria Pasquarella; Carmine Romano; Carmelo Alfrone; Felice Strollo
Journal:  Diabetes Ther       Date:  2021-03-18       Impact factor: 2.945

6.  A suitable palpation technique allows to identify skin lipohypertrophic lesions in insulin-treated people with diabetes.

Authors:  Sandro Gentile; Giuseppina Guarino; Annalisa Giancaterini; Piero Guida; Felice Strollo
Journal:  Springerplus       Date:  2016-05-05

Review 7.  Lipodystrophy in Insulin-Treated Subjects and Other Injection-Site Skin Reactions: Are We Sure Everything is Clear?

Authors:  Sandro Gentile; Felice Strollo; Antonio Ceriello
Journal:  Diabetes Ther       Date:  2016-07-25       Impact factor: 2.945

8.  Lipodistrophy and Associated Risk Factors in Insulin-Treated People With Diabetes.

Authors:  Sandro Gentile; Felice Strollo; Antonio Ceriello
Journal:  Int J Endocrinol Metab       Date:  2016-04-26

Review 9.  Forum for Injection Technique and Therapy Expert Recommendations, India: The Indian Recommendations for Best Practice in Insulin Injection Technique, 2017.

Authors:  Nikhil Tandon; Sanjay Kalra; Yatan Pal Singh Balhara; Manash P Baruah; Manoj Chadha; Hemraj B Chandalia; K M Prasanna Kumar; S V Madhu; Ambrish Mithal; Rakesh Sahay; Rishi Shukla; Annamalai Sundaram; Ambika G Unnikrishnan; Banshi Saboo; Vandita Gupta; Subhankar Chowdhury; Jothydev Kesavadev; Subhash K Wangnoo
Journal:  Indian J Endocrinol Metab       Date:  2017 Jul-Aug

10.  Turkish Insulin Injection Techniques Study: Complications of Injecting Insulin Among Turkish Patients with Diabetes, Education They Received, and the Role of Health Care Professional as Assessed by Survey Questionnaire.

Authors:  Selcuk Dagdelen; Oguzhan Deyneli; Nermin Olgun; Zeynep Osar Siva; Mehmet Sargin; Sükrü Hatun; Mustafa Kulaksizoglu; Ahmet Kaya; Cansu Aslan Gürlek; Laurence J Hirsch; Kenneth W Strauss
Journal:  Diabetes Ther       Date:  2018-06-30       Impact factor: 2.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.